Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, July 10, 2015 1:05:13 PM
bullish
## source: finance.yahoo.com
Fri, 26 Jun 2015 11:30:00 GMT ~ Summers Small Cap Stock Portfolio
[Accesswire] - CORAL GABLES, FL / ACCESSWIRE / June 26, 2015 / Continued overhang from the crisis in Greece continue to weigh down the larger markets. In the larger markets, the standstill to finalize decisions has negatively ...
read full: http://finance.yahoo.com/news/summers-small-cap-stock-portfolio-113000631.html
*********************************************************
Tue, 09 Jun 2015 11:02:00 GMT ~ RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform
[PR Newswire] - MARLBOROUGH, Mass., June 9, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received two Notices of Allowance from the United States Patent and Trademark Office (USPTO). One is on RXi's novel, self-delivering RNAi platform (sd-rxRNA®). The patent, titled "Reduced Size Self-Delivering RNAi Compounds," covers both the composition and methods of use of RXi's self-delivering platform. The patent, once issued, will be scheduled to expire in 2031.
read full: http://finance.yahoo.com/news/rxi-pharmaceuticals-strengthens-intellectual-property-110200033.html
*********************************************************
Mon, 08 Jun 2015 11:20:00 GMT ~ The Rising Tide in Larger Markets Spurs New Interest In Small-Cap Stocks
[Accesswire] - CORAL GABLES, FL / ACCESSWIRE / June 8, 2015 / Oil analysts are starting to lean toward a more favorable outcome for oil prices in relation to a prosperous global economy. With that, markets have continued ...
read full: http://finance.yahoo.com/news/rising-tide-larger-markets-spurs-112000646.html
*********************************************************
Thu, 04 Jun 2015 20:32:24 GMT ~ RXI PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/150604/rxii8-k.html
*********************************************************
Thu, 04 Jun 2015 18:30:00 GMT ~ 3 Stocks Under $10 to Trade for Breakouts
read full: http://www.thestreet.com/story/13175940/1/3-stocks-under-10-to-trade-for-breakouts.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
$RXII charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RXII company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RXII/company-info
Ticker: $RXII
OTC Market Place: Not Available
CIK code: 0001533040
Company name: RXI Pharmaceuticals Corporation
Company website: http://www.rxipharma.com
Incorporated In: DE, USA
Business Description: RXi Pharmaceuticals Corporation (OTCQX:RXII) is a biotechnology company focused on discovering, developing, and commercializing innovative therapies based on its proprietary, next-generation RNAi platform. Therapeutics that use RNA interference, or \"RNAi,\" have great promise because of their ability to \"silence\" or down-regulate, the expression of a specific gene that may be expressed in a disease condition. Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, RXi's first RNAi product candidate, RXI-109, entered into RXi's first human trial in 2012. RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation, and is initially being developed to reduce or inhibit scar formation in the skin following surgery.Less >>
$RXII share structure
## source: otcmarkets.com
Market Value: $17,436,406 a/o Jul 09, 2015
Shares Outstanding: 36,160,113 a/o May 08, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$RXII extra dd links
Company name: RXI Pharmaceuticals Corporation
Company website: http://www.rxipharma.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RXII/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RXII/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RXII+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RXII+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RXII+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RXII/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RXII/news - http://finance.yahoo.com/q/h?s=RXII+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RXII/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RXII/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RXII/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RXII/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RXII/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RXII/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RXII/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RXII/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RXII+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RXII
DTCC (dtcc.com): http://search2.dtcc.com/?q=RXI+Pharmaceuticals+Corporation&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=RXI+Pharmaceuticals+Corporation
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=RXI+Pharmaceuticals+Corporation&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.rxipharma.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.rxipharma.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.rxipharma.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RXII/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RXII
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RXII/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RXII/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RXII/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001533040&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RXII/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RXII/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RXII/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RXII/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RXII&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RXII
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RXII/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RXII+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RXII+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RXII
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RXII
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RXII+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RXII/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RXII+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RXII.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RXII
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RXII/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RXII/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RXII/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RXII/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RXII
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RXII
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RXII:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RXII
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RXII
$RXII DD Notes ~ http://www.ddnotesmaker.com/RXII
Recent PHIO News
- Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO) • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells • GlobeNewswire Inc. • 04/22/2024 05:10:09 PM
- Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID) • GlobeNewswire Inc. • 04/16/2024 11:30:00 AM
- Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT) • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- National Spotlight Features Phio’s Innovative RNAi Technology Platform • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
- Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
- Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research • GlobeNewswire Inc. • 03/13/2024 06:00:25 PM
- Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders • GlobeNewswire Inc. • 03/06/2024 03:30:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:00:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 12:03:51 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:30:10 PM
- Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:00:16 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/28/2023 02:13:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/28/2023 05:15:20 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/19/2023 09:52:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:00:32 PM
- Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds • GlobeNewswire Inc. • 12/07/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:40:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:07 PM
- Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/09/2023 09:30:20 PM
- Phio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomas • GlobeNewswire Inc. • 11/09/2023 12:30:00 PM
- Phio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor Control • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM